http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1297835-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-153 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4741 |
filingDate | 2002-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d67e70f7aac7a1972faae9131fc64d88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94f3019bde53714dee2d6f945df545e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66c8a2986ce4f83135833b5459084446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d62317382cbd3c03a124be6d51bd5c79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10d3f44ebfe8dc5a72754deed4d327c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_658b2627a3b552d6889b7cf5bfbcc622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0091c401b5a5fe68574594d9483321c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b5294e2bb3874997343ac1d1397f7cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94edfb8cf668db57831d66f905c467b1 |
publicationDate | 2003-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1297835-A1 |
titleOfInvention | Benzo[b]pyrano[3,2-h]acridin-7-one derivatives, processes for their preparation and pharmaceutical compositions thereof |
abstract | X et Y représentent un groupement choisi parmi hydrogène, halogène, mercapto,ncyano, nitro, alkyle, trihalogénoalkyle, trihalogénoalkylcarbonylamino, ORa, NRaRb,n-NRa-C(O)-T 1 , -O-C(O)-T 1 , -O-T 2 -NRaRb, -O-T 2 -ORa, -NRa-T 2 -NRaRb, -NRa-T 2 -ORa,net -NRa-T 2 -CO 2 Ra dans lesquels Ra, Rb, T 1 , T 2 sont tels que définis dans la description, ounX et Y forment ensemble un groupement méthylènedioxy ou éthylènedioxy, R 1 représente un atome d'hydrogène ou un groupement alkyle, R 2 représente un groupement choisi parmi hydrogène, ORa, NRaRb, -NRa-C(O)-T 1 ,n-O-C(O)-T 1 ,-O-T 2 -NRaRb,-O-T 2 -ORa,-NRa-T 2 -NRaRb, -NRa-T 2 -ORa, et -NRa-T 2 -CO 2 Randans lesquels Ra, Rb, T 1 et T 2 sont tels que définis précédemment, R 3 et R 4 représentent un atome d'hydrogène ou un groupement alkyle, W représente un groupement de formule -CH(R 5 )-CH(R 6 )-, -CH=C(R 7 )-, -C(R 7 )=CH-nou -C(O)-CH(R 8 )- dans lesquelles R 5 , R 6 , R 7 et R 8 sont tels que définis dans la description,nleurs isomères, N-oxydes, ainsi que leurs sels d'addition à un acide ou à une basenpharmaceutiquement acceptable. Compounds of formula (I): in which : X and Y represent a group chosen from hydrogen, halogen, mercapto, cyano, nitro, alkyl, trihaloalkyl, trihaloalkylcarbonylamino, ORa, NRaRb, -NRa-C (O) -T 1 , -OC (O) -T 1 , -OT 2 -NRaRb, -OT 2 -ORa, -NRa-T 2 -NRaRb, -NRa-T 2 -ORa, and -NRa-T 2 -CO 2 Ra in which Ra, Rb, T 1 , T 2 are such that defined in the description, where X and Y together form a methylenedioxy or ethylenedioxy group, R 1 represents a hydrogen atom or an alkyl group, R 2 represents a group chosen from hydrogen, ORa, NRaRb, -NRa-C (O) -T 1 , -OC (O) -T 1 , -OT 2 -NRaRb, -OT 2 -ORa, -NRa-T 2 -NRaRb, -NRa-T 2 -ORa, and -NRa-T 2 -CO 2 Ra in which Ra, Rb, T 1 and T 2 are as defined previously, R 3 and R 4 represent a hydrogen atom or an alkyl group, W represents a group of formula -CH (R 5 ) -CH (R 6 ) -, -CH = C (R 7 ) -, -C (R 7 ) = CH- or -C (O) -CH (R 8 in which R 5 , R 6 , R 7 and R 8 are as defined in the description, their isomers, N-oxides, as well as their addition salts with a pharmaceutically acceptable acid or base. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2865734-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1561753-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1561753-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2879600-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SG-146431-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1674101-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1491544-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2856687-A1 |
priorityDate | 2001-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 169.